New Outcomes Data Demonstrating Prolonged Survival for Inoperable Pancreatic Cancer Patients
UF startup ViewRay, Inc., a leading medical technology company that provides groundbreaking MRI-guided radiation therapy, announced that the results of a multi-center study of 148 inoperable pancreatic cancer patients treated with MRIdian SMART (MR-guided stereotactic adaptive radiation therapy) were presented as part of the Annual Meeting of the American Society for Radiation Oncology (ASTRO), the world’s largest radiation oncology society.
ViewRay Announces 510(k) Pending Status of the Newest Generation of MRIdian Innovations
UF startup ViewRay, Inc., a leading medical technology company that provides groundbreaking MRI-guided radiation therapy, announced that the company has received acceptance from the FDA on their recent submission for new MRIdian features focused on enhancing on-table adaptive workflow efficiency and expanding clinical utility.
Amsterdam University Medical Centers Treats 1,000th Patient With MRIdian SMART MRI-Guided Radiation Therapy
UF startup ViewRay, Inc., a leading medical technology company that provides groundbreaking MRI-guided radiation therapy, announced that the clinical team at Amsterdam University Medical Centers (Amsterdam UMC) has treated one thousand patients using MRIdian SMART (stereotactic MR-guided adaptive radiotherapy). Amsterdam UMC continues to advance the practice of high-dose ablative radiation therapy with MRIdian through research […]
ASTRO 2020 to Feature Latest MRIdian Clinical Experience Highlighting Outcomes in Tough to Treat Cancer
UF startup ViewRay Inc., a leading medical technology company that provides groundbreaking MRI-guided radiation therapy, announced that the company’s MRIdian® Linac MRI-guided radiation therapy system will be featured at the 2020 Annual Meeting of the American Society for Radiation Oncology (ASTRO), being held virtually October 24 to 28, 2020. The meeting will feature presentations that […]
Providence Portland Medical Center Begins Patient Treatments With ViewRay’s MRIdian Linac
UF startup ViewRay, Inc. announced that Providence Portland Medical Center in Portland, Oregon has begun patient treatments with the MRIdian® MR-Guided Therapy System, a cutting-edge radiation therapy system that combines the latest innovations in precision radiation delivery and ground-breaking MR-guidance. The MRIdian system at Providence Portland Medical Center is part of The Elsie Franz Finley Radiation Oncology Center […]
New Hope for Patients Battling Inoperable Cancer
Doctors at Sparrow’s Herbert-Herman Cancer Center in Lansing, Michigan have a new tool to deliver radiation. It’s one of only 12 in the country. UF startup ViewRay, Inc. MRIdian machine allows doctors to attack tumors with precision in real-time, giving patients with inoperable cancers new hope. ViewRay, Inc. is a leading medical technology company that provides groundbreaking MRI-guided radiation therapy. […]
ASTRO 2019 to Feature Clinical Experience and Patient Outcomes With Viewray MRIdian
UF startup ViewRay, Inc., a leading medical technology company that provides groundbreaking MRI-guided radiation therapy, announced that the company’s MRIdian and MRIdian Linac magnetic resonance imaging (MRI)-guided radiation therapy systems will be featured at the 2019 annual meeting of the American Society for Radiation Oncology (ASTRO). The meeting will feature a number of presentations highlighting […]
MRIdian System Limits Early Toxicity for Prostate Cancer Without Implanted Markers
UF startup ViewRay Inc., a leading medical technology company that provides groundbreaking MRI-guided radiation therapy, announced the acceptance of publication by the International Journal of Radiation Oncology, Biology and Physics of the first prospective clinical trial of MR-guided radiation therapy (MRgRT) in patients with localized prostate cancer. This robust study of clinician and patient-reported outcomes […]
FDA Clears Advancements for Viewray MRIdian Radiation Therapy System
UF startup ViewRay Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market new soft tissue visualization capabilities for its MRIdian image-guided radiation therapy (IGRT) system. The new upgradable capabilities enhance the features of MRIdian’s SmartVISION MRI (magnetic resonance imaging), including: Expanded high-definition visualization and enhanced contrast between different tissues, to […]
ViewRay to Supply UK’s GenesisCare With Country’s First MRIdian Systems (DOTmed)
UF startup ViewRay Inc. is set to deliver the first of Great Britain’s MRIdian MR-guided radiotherapy systems as part of a new partnership between it and the cancer service provider, GenesisCare. Deployed within the GenesisCare network, the first two systems will offer oncologists the ability to leverage soft-tissue imaging for the visualization of tumors, personalizing […]